Glucosamine and osteoarthritis: Prescribed regimen is effective

BMJ (Online)

Volumn 341, Issue 7781, 2010, Pages 1110-

  Reginster, Jean Yves ^b   Altman, Roy D ^a,c   Hochberg, Marc C ^a,d  

^a Department of Medicine ^*  (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE; GLUCOSAMINE SULFATE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SYNTHESIS; HUMAN; KNEE OSTEOARTHRITIS; LETTER; OSTEOARTHRITIS; PRESCRIPTION; PRIORITY JOURNAL;

EID: 78349240535     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c6335     Document Type: Letter

References (7)

1. Wandel S, Jüni P, Tendal B, Nüesch E, Villiger PM, Welton NJ, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010;341:c4675. (16 September.)
2. Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2009;2:CD002946.
3. Reginster JY. The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest. Arthritis Rheum 2007;56:2105-10.
4. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62.
5. (Updated in Osteoarthritis Cartilage 2010;18:476-99.)
6. Vlad SC, LaValley MP, McAlindon TE, Felson DT. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum 2007;56:2267-77.
7. Altman RD. Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations. Expert Rev Clin Pharmacol 2009;2:359-71.